FR2906806B1 - Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant - Google Patents

Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant

Info

Publication number
FR2906806B1
FR2906806B1 FR0608836A FR0608836A FR2906806B1 FR 2906806 B1 FR2906806 B1 FR 2906806B1 FR 0608836 A FR0608836 A FR 0608836A FR 0608836 A FR0608836 A FR 0608836A FR 2906806 B1 FR2906806 B1 FR 2906806B1
Authority
FR
France
Prior art keywords
dendritic
processes
production
pharmaceutical compositions
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0608836A
Other languages
English (en)
Other versions
FR2906806A1 (fr
Inventor
Flesch Delphine Felder
Jerome Steibel
Annabelle Bertin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Centre National de la Recherche Scientifique CNRS
Universite Louis Pasteur Strasbourg I
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Louis Pasteur Strasbourg I
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Louis Pasteur Strasbourg I filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR0608836A priority Critical patent/FR2906806B1/fr
Priority to PCT/FR2007/001645 priority patent/WO2008043911A2/fr
Priority to US12/444,817 priority patent/US8404216B2/en
Priority to EP07858413A priority patent/EP2079682A2/fr
Priority to JP2009531870A priority patent/JP5149905B2/ja
Publication of FR2906806A1 publication Critical patent/FR2906806A1/fr
Application granted granted Critical
Publication of FR2906806B1 publication Critical patent/FR2906806B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/124—Macromolecular compounds dendrimers, dendrons, hyperbranched compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/76—Metal complexes of amino carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G83/00—Macromolecular compounds not provided for in groups C08G2/00 - C08G81/00
    • C08G83/002—Dendritic macromolecules

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Polymers & Plastics (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR0608836A 2006-10-09 2006-10-09 Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant Expired - Fee Related FR2906806B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR0608836A FR2906806B1 (fr) 2006-10-09 2006-10-09 Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant
PCT/FR2007/001645 WO2008043911A2 (fr) 2006-10-09 2007-10-09 Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant
US12/444,817 US8404216B2 (en) 2006-10-09 2007-10-09 Dendritic chelated compounds, methods for making the same and pharmaceutical compositions containing the same
EP07858413A EP2079682A2 (fr) 2006-10-09 2007-10-09 Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant
JP2009531870A JP5149905B2 (ja) 2006-10-09 2007-10-09 樹状キレート化合物、該化合物の製造方法及び該化合物を含有する医薬組成物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0608836A FR2906806B1 (fr) 2006-10-09 2006-10-09 Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
FR2906806A1 FR2906806A1 (fr) 2008-04-11
FR2906806B1 true FR2906806B1 (fr) 2012-12-14

Family

ID=38099018

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0608836A Expired - Fee Related FR2906806B1 (fr) 2006-10-09 2006-10-09 Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant

Country Status (5)

Country Link
US (1) US8404216B2 (fr)
EP (1) EP2079682A2 (fr)
JP (1) JP5149905B2 (fr)
FR (1) FR2906806B1 (fr)
WO (1) WO2008043911A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8227628B2 (en) 2008-07-09 2012-07-24 Northwestern University Method of synthesizing acetonide-protected catechol-containing compounds and intermediates produced therein
KR101171483B1 (ko) * 2010-02-16 2012-08-07 대림산업 주식회사 글리콜 모노-터셔리-부틸에테르 화합물의 제조 방법 및 이에 의해 제조된 글리콜 모노-터셔리-부틸에테르 화합물
FR2959227B1 (fr) * 2010-04-23 2012-06-22 Centre Nat Rech Scient Nano-objets magneto-optiques pour la detection des cancers
EP2428503B1 (fr) * 2010-09-10 2014-12-10 Justus-Liebig-Universität Gießen Synthèse de dérivés de catéchol tripodaux flexibles pour la fonctionnalisation de surfaces
US9623127B2 (en) * 2011-11-18 2017-04-18 Centre National De La Recherche Scientifique Multimodal contrast and radiopharmaceutical agent for an imaging and a targeted therapy guided by imaging
FR2995902B1 (fr) * 2012-09-26 2014-11-21 Centre Nat Rech Scient Nouveaux composes comportant des groupements dendrimeriques iodes ou fluores, leurs procedes de preparation et leurs utilisations
FR3005954A1 (fr) * 2013-05-23 2014-11-28 Univ Strasbourg Composes dendritiques comprenant un agent chelatant, fluorochrome ou agent de reconnaissance, compositions les comprenant et leurs utilisations
EP2996726A1 (fr) * 2013-05-16 2016-03-23 Université de Strasbourg Composés dendritiques comprenant un agent chélatant, fluorochrome ou agent de reconnaissance, compositions les comprenant et leurs utilisations
EP3166553A4 (fr) * 2014-07-11 2018-02-14 The University of Akron Composition et procédés de fixation de peptides biologiquement actifs sur des surfaces d'oxydes métalliques
KR101625656B1 (ko) * 2015-10-16 2016-05-30 최경석 자기공명영상용 조영제의 제조방법
GB201613166D0 (en) * 2016-07-29 2016-09-14 Vectura Ltd Polymer
CN106883252B (zh) * 2017-03-21 2021-12-17 江汉大学 一种具有高磁熵变的环形钆配合物及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5527524A (en) * 1986-08-18 1996-06-18 The Dow Chemical Company Dense star polymer conjugates
US5756726A (en) * 1995-06-02 1998-05-26 Pharmacyclics, Inc. Methods of producing singlet oxygen using compounds having improved functionalization
US6982324B1 (en) * 2001-11-13 2006-01-03 University Of Utah Research Foundation Degradable macromolecular magnetic resonance imaging contrast agents and methods thereof
FR2867473B1 (fr) * 2004-03-12 2006-06-23 Guerbet Sa Compose de porphyrines et utilisation a haut champ en irm
US20060018835A1 (en) * 2004-04-02 2006-01-26 General Electric Company Nanoparticles with inorganic core and methods of using them
AU2005287375B8 (en) * 2004-08-25 2009-11-12 The Regents Of The University Of Michigan Dendrimer based compositions and methods of using the same
TWI278475B (en) * 2004-12-30 2007-04-11 Ind Tech Res Inst A dendrite compound and its use
US20080112891A1 (en) * 2005-02-15 2008-05-15 Dendritic Nanotechnologies, Inc. Encapsulated (Chelate or Ligand) Dendritic Polymers
FR2883562B1 (fr) * 2005-03-24 2009-02-27 Guerbet Sa Chelates lipophiles et leur utilisation en imagerie
US20100298403A1 (en) * 2005-07-08 2010-11-25 Janssen Pharmaceutica N.V. MODIFIED POLY(PROPYLENE-IMINE) DENDRIMERS AND THEIR USE AS TRANSFECTION AGENTS FOR AMIONIC BIOACTIVE FACTORS ( as amended

Also Published As

Publication number Publication date
WO2008043911A2 (fr) 2008-04-17
JP5149905B2 (ja) 2013-02-20
WO2008043911A3 (fr) 2014-12-18
EP2079682A2 (fr) 2009-07-22
JP2010507571A (ja) 2010-03-11
FR2906806A1 (fr) 2008-04-11
US8404216B2 (en) 2013-03-26
US20100104512A1 (en) 2010-04-29

Similar Documents

Publication Publication Date Title
FR2906806B1 (fr) Complexes chelates dendritiques, leurs procedes de fabrication et compositions pharmaceutiques les contenant
EG25629A (en) Heteromolecular metal-humic 'chelate' complexes
FR2915682B1 (fr) Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
IL197718A0 (en) Pharmaceutical compositions of hdac inhibitors and chelatable metal compounds, and metal-hdac inhibitors chelate complexes
BRPI0909738A2 (pt) composições farmacêuticas aquosas contendo complexos de boratopoliol
ZA201000912B (en) Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives,method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors
DE602007014370D1 (de) Fettsäuredesaturasen aus tetraselmis suecica
ATE538652T1 (de) Synergistische pharmazeutische kombination für die behandlung von krebs
DK1962873T3 (da) Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier
EP2057987A4 (fr) Composition pharmaceutique contenant une nanoparticule de statine encapsulée
BRPI0911847A2 (pt) composições de pastilhas de nicotina
ATE536355T1 (de) 3,3-spiroindolinionderivate als antikrebsmittel
ITBO20060719A1 (it) Macchina per la produzione di filtri composti.
DK2442790T3 (da) Vandige farmaceutiske sammensætninger, indeholdende borat-polyolkomplekser
EP1871363A4 (fr) Processus a etapes combinees pour compositions pharmaceutiques
ATE460401T1 (de) 1,2,4,5-tetrahydro-3h-benzazepinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
ITBO20060749A1 (it) Macchina confezionatrice di filtri per articoli da fumo
IL227565A (en) Salts of hexahydropananthridine preserved in position 5 of the heterocyclic group and pharmaceutical preparations containing them
ITBO20060720A1 (it) Macchina per la produzione di filtri composti.
FI20080624A0 (fi) Kelaatteja, kelatoivia yhdisteitä ja niistä johdettuja konjugaatteja
IS7748A (is) Samsetning fyrir töflur sem innihalda topiramate
DE502007003531D1 (de) Verfahren zum herstellen von alkylaniliden aus halogenbenzolderivaten
DK2094638T3 (da) 2-aryl-2-fluorpropansyrer og derivater og farmaceutiske sammensætninger, der indeholder dem
DK1948126T3 (da) Oral sammensætning indeholdende morin
FR2918560B1 (fr) Composition cosmetique contenant un derive de dibenzoylmethane et un compose phenanthrenol ; procede de photostabilisation du derive de dibenzoylmethane.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20160630